Showing results (21-30 of 714) with videos related to
Sort By:
Pageof 72
The Lancet. Neurology|March 17, 2007
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?Patrick G Kehoe, Gordon K WilcockJournal of Neurology, Neurosurgery, and Psychiatry|January 1, 1984
The olfactory bulbs in Alzheimer's diseaseM M Esiri, G K WilcockNeuropathology and Applied Neurobiology|June 6, 2003
APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta proteinK Chalmers, G K Wilcock, S LoveNeuroreport|May 28, 1998
Apoptosis and expression of DNA repair proteins in ischaemic brain injury in manS Love, R Barber, G K WilcockBMJ (Clinical Research Ed.)|December 9, 2000
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study GroupG K Wilcock, S Lilienfeld, E GaensActa Neuropathologica|September 1, 2005
Loss of perineuronal net N-acetylgalactosamine in Alzheimer's diseaseShabnam Baig, Gordon K Wilcock, Seth LoveJournal of American College Health : J of ACH|September 1, 1996
Substance-free residence halls: the promise and the practiceP FinnJournal of Speech and Hearing Research|December 1, 1996
Establishing the validity of recovery from stuttering without formal treatmentP FinnJournal of Psychoactive Drugs|April 1, 1996
Program administrator and medical staff attitudes toward six hypothetical medications for substance abuse treatmentP FinnJournal of Substance Abuse Treatment|July 1, 1994
Addressing the needs of cultural minorities in drug treatmentP FinnPageof 72